Skip to content
Dose Brief
Menu
No. 8 on the board · Grade B+

Vaylen review

A full-service, LegitScript-certified desk pairing brand access and an oral route with nationwide reach at a fair mid price.

Visit Vaylen Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$179/mo
Tirzepatide
$239/mo
Coverage
All 50 states
Brand-name
Yes
On the trackerStableprice stable$179 sema / $239 tirz; brand + oral + LegitScript across all 50 states.

The scorecard

Vaylen scored on our six Brief Score factors. See the methodology.

Price Stability85/100
Supply Reliability87/100
Transparency87/100
Access Breadth92/100
Clinical Oversight88/100
Track Record82/100

What we like

  • Brand-name, compounded and oral options in one place
  • LegitScript-certified, all 50 states
  • Mid-market pricing ($179/$239)

The caveats

  • Short public track record
  • Compounded pricing not the cheapest

The brief

Best for: Readers who want brand, compounded and oral options from one accredited nationwide desk without a premium sticker. A full-service, LegitScript-certified desk pairing brand access and an oral route with nationwide reach at a fair mid price.

Ranked #8 of 25 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 24 other providers we've reviewed, in our overall ranking order.

Pricing, states and verification reflect Vaylen's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Vaylen's site. Not medical advice; see our disclosure.

← Back to all rankings